日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients

在 BCR::ABL1 数字 PCR 选择的 CML 患者临床队列中,无治疗缓解的结果

Kockerols, C; Valk, P J M; Hogenbirk, P; Geelen, I; Blijlevens, N M A; Janssen, J J W M; Hoogendoorn, M; Kersting, S; Klein, S K; Daenen, L G M; Donker, M; Te Boekhorst, P A W; Jie, K-S G; Corsten, M; Cruijsen, M J; Levenga, H; Smit, W M; Levin, M-D; de Jongh, E; de Jonge, S; Vlot, A J; Durian, M F; Zwaginga, J J; Mohlmann, M; Wustman, T J; Blommers, R; Cornelissen, J J; Westerweel, P E

Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population

在真实世界中多重耐药慢性粒细胞白血病患者人群中,asciminib 的治疗模式和临床结果

Kockerols, Camille C B; Janssen, Jeroen J W M; Blijlevens, Nicole M A; Klein, Saskia K; Van Hussen-Daenen, Laura G M; Van Gorkom, Gwendolyn G Y; Smit, Willem M; Van Balen, Peter; Biemond, Bart J; Cruijsen, Marjan J; Corsten, Maarten F; Te Boekhorst, Peter A W; Koene, Harry R; Van Sluis, Geerte L; Cornelissen, Jan J; Westerweel, Peter E

High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population

荷兰慢性期慢性粒细胞白血病患者人群中高风险的额外细胞遗传学异常

Kockerols, Camille C B; Geelen, Inge G P; Levin, Mark-David; Janssen, Jeroen J W M; Berna Beveloo, H; Dinmohamed, Avinash G; Hoogendoorn, Mels; Cornelissen, Jan J; Westerweel, Peter E

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

在当前酪氨酸激酶抑制剂时代,羟基脲预处理在慢性粒细胞白血病中的应用

Kockerols, Camille C B; Geelen, Inge; Levin, Mark-David; Janssen, Jeroen J W M; Dinmohamed, Avinash G; Hoogendoorn, Mels; Cornelissen, Jan J; Westerweel, Peter E

Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice

数字PCR在慢性粒细胞白血病中BCR-ABL1定量检测中的应用:目前在临床实践中的应用

Kockerols, Camille C B; Valk, Peter J M; Levin, Mark-David; Pallisgaard, Niels; Cornelissen, Jan J; Westerweel, Peter E